SMS Education for Post-operative Pain
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04039191|
Recruitment Status : Recruiting
First Posted : July 31, 2019
Last Update Posted : May 14, 2020
|Condition or disease||Intervention/treatment||Phase|
|Opioid Use Pain, Postoperative||Behavioral: SMS education Behavioral: SMS survey||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||250 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|
|Official Title:||Short Messaging Service (SMS) Education for Post-operative Pain|
|Actual Study Start Date :||December 9, 2019|
|Estimated Primary Completion Date :||December 2020|
|Estimated Study Completion Date :||December 2020|
Placebo Comparator: SMS survey
Subject to receive SMS survey.
Behavioral: SMS survey
Patients will receive survey questions about post-operative pain and opioid use but no education
Active Comparator: SMS survey with education
Subject to receive SMS survey with education.
Behavioral: SMS education
Patients will receive additional educational SMS messages post-operatively
- Number of opioid pills consumed [ Time Frame: 10 days post-op ]Number of opioid pills consumed
- Post-operative pain scores [ Time Frame: 10 days post-op ]
Pain score will be utilizing a numeric pain rating scale (0-10) where 0 corresponds to no pain and 10 to worst pain.
Total pain score will be reported as well as total scaled pain score which is total pain score divided by response rate.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04039191
|Contact: Yufei Chen, MDemail@example.com|
|United States, California|
|Cedars Sinai Medical Center||Recruiting|
|Los Angeles, California, United States, 90048|
|Contact: Yufei Chen, MD 310-423-5495 firstname.lastname@example.org|
|Principal Investigator: Yufei Chen|
|Principal Investigator:||Yufei Chen, MD||Cedars-Sinai Medical Center|